atorvastatin has been researched along with Chagas Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Estrada, C; Denegri, M; González-Herrera, F; Kemmerling, U; Maya, JD; Urarte, E; Villalón, L | 1 |
| Anfossi, R; Carrillo, I; Castillo, C; Catalán, M; Clayton, NS; González-Herrera, F; Guzmán-Rivera, D; Kemmerling, U; Maya, JD; Olea-Azar, C; Quilaqueo, ME; Quintero-Pertuz, H; Ridley, AJ; Rivera-Meza, M; Vivar, R | 1 |
| Araujo-Lima, CF; Bastos, MM; Boechat, N; Carvalho, RCC; Castelo-Branco, FS; Felzenszwalb, I; Fiuza, LFA; Galvão, BVD; Peres, RB; Soeiro, MNC | 1 |
| Aiub, CAF; Araujo-Lima, CF; Batista, MM; Felzenszwalb, I; Peres, RB; Silva, PB; Soeiro, MNC | 1 |
1 trial(s) available for atorvastatin and Chagas Disease
| Article | Year |
|---|---|
Effect of statins on inflammation and cardiac function in patients with chronic Chagas disease: A protocol for pathophysiological studies in a multicenter, placebo-controlled, proof-of-concept phase II trial.
Topics: Atorvastatin; Chagas Disease; Clinical Trials, Phase II as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Multicenter Studies as Topic; Nitroimidazoles; Persistent Infection; Randomized Controlled Trials as Topic; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
3 other study(ies) available for atorvastatin and Chagas Disease
| Article | Year |
|---|---|
Statins change the cytokine profile in
Topics: Animals; Atorvastatin; Cardiomyopathies; Chagas Disease; Cytokines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Macrophages; Mice; NF-kappa B; rho-Associated Kinases; Trypanosoma cruzi; U937 Cells | 2022 |
In silico and in vitro assessment of anti-Trypanosoma cruzi efficacy, genotoxicity and pharmacokinetics of pentasubstituted pyrrolic Atorvastatin-aminoquinoline hybrid compounds.
Topics: Aminoquinolines; Animals; Antimalarials; Atorvastatin; Chagas Disease; DNA Damage; Mice; Pharmaceutical Preparations; Pyrroles; Trypanocidal Agents; Trypanosoma cruzi | 2023 |
Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Topics: Animals; Atorvastatin; Cell Line; Chagas Disease; Drug Repositioning; Drug Synergism; Drug Therapy, Combination; Heart; Mice; Nitroimidazoles; Parasitic Sensitivity Tests; Trypanocidal Agents; Trypanosoma cruzi | 2018 |